Clinical Microbiology Reviews

Papers
(The TQCC of Clinical Microbiology Reviews is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Extracutaneous sporotrichosis337
Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utility181
Transmission of Infections during Cardiopulmonary Resuscitation170
Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections144
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders118
Erratum for Nyaruaba et al., “Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks”116
Antibiotic tolerance among clinical isolates: mechanisms, detection, prevalence, and significance108
The long reach of influenza and other respiratory viruses: from acute epithelial injury to post-viral lung disease103
Progression of antibiotic resistance in Neisseria meningitidis98
Membrane Technology for Rapid Point-of-Care Diagnostics for Parasitic Neglected Tropical Diseases97
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options92
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant89
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus88
Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities83
Viral infections and pathogenesis of glaucoma: a comprehensive review78
Emerging hybrid shigatoxigenic and enteropathogenic Escherichia coli serotype O80:H2 in humans and calves78
Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics73
Non- faecium non- faecalis enterococci: a review of clinical manifestations, virulence factors, and antimicrobial resistance69
Evolutionary Pathways and Trajectories in Antibiotic Resistance69
Review of BCG immunotherapy for bladder cancer67
Congenital Syphilis: a Review of Global Epidemiology64
Clonorchiasis and opisthorchiasis: epidemiology, transmission, clinical features, morbidity, diagnosis, treatment, and control62
Neisseria gonorrhoeae vaccines: a contemporary overview60
Extrapolation and comparison of West Nile virus- and Usutu virus-associated neurological diseases in humans: linking pathology to clinical symptoms59
Bacillus cereus Invasive Infections in Preterm Neonates: an Up-to-Date Review of the Literature57
Bacterial and fungal infections in persons who inject drugs54
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease52
BCG therapy in bladder cancer and its tumor microenvironment interactions52
Diagnosis, Management, and Future Control of Cholera52
Rapid and accurate testing for urinary tract infection: new clothes for the emperor50
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes50
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections49
Aspergillus terreus Species Complex48
Trained Immunity as a Preventive Measure for Surgical Site Infections48
Agnostic Sequencing for Detection of Viral Pathogens47
Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome47
Harnessing the host response for precision infectious disease diagnosis46
Artemisinin-resistant malaria44
Lyme borreliosis in Brazil: a critical review on the Baggio–Yoshinari syndrome (Brazilian Lyme-like disease)43
Editorial Board42
COVID-19 therapeutics39
2021 Acknowledgment of CMR Reviewers39
The challenges of difficult-to-treat Acinetobacter infections38
Pneumocystis jirovecii pneumonia in people living with HIV: a review38
Pathogenesis of viral infections during pregnancy38
0.03610897064209